PPARA (peroxisome proliferator activated receptor alpha)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
5465 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Peroxisome proliferator activated receptor alpha |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
PPARA |
SynonymsGene synonyms aliases
|
NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR |
ChromosomeChromosome number
|
22 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
22q13.31 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
Peroxisome proliferators include hypolipidemic drugs, herbicides, leukotriene antagonists, and plasticizers; this term arises because they induce an increase in the size and number of peroxisomes. Peroxisomes are subcellular organelles found in plants and animals that contain enzymes for respiration and for cholesterol and lipid metabolism. The action of peroxisome proliferators is thought to be mediated via specific receptors, called PPARs, which belong to the steroid hormone receptor superfamily. PPARs affect the expression of target genes involved in cell proliferation, cell differentiation and in immune and inflammation responses. Three closely related subtypes (alpha, beta/delta, and gamma) have been identified. This gene encodes the subtype PPAR-alpha, which is a nuclear transcription factor. Multiple alternatively spliced transcript variants have been described for this gene, although the full-length nature of only two has been determined. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs1800206 |
C>G |
Risk-factor |
Coding sequence variant, non coding transcript variant, missense variant, synonymous variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT000630 |
hsa-miR-519d-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
20057369 |
MIRT002473 |
hsa-miR-22-3p |
Western blot |
18347104 |
MIRT002473 |
hsa-miR-22-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
19011694 |
MIRT005068 |
hsa-miR-10b-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
19780876 |
MIRT006422 |
hsa-miR-21-5p |
Luciferase reporter assay, Flow, Immunoprecipitaion, In situ hybridization, qRT-PCR, Western blot |
21636785 |
MIRT006422 |
hsa-miR-21-5p |
Microarray |
18591254 |
MIRT006422 |
hsa-miR-21-5p |
Immunofluorescence, Immunohistochemistry, Immunoprecipitaion, Luciferase reporter assay, qRT-PCR, Western blot |
24012640 |
MIRT006422 |
hsa-miR-21-5p |
qRT-PCR, Western blot |
26338827 |
MIRT006709 |
hsa-miR-141-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
22479552 |
MIRT017974 |
hsa-miR-335-5p |
Microarray |
18185580 |
MIRT022715 |
hsa-miR-124-3p |
Microarray |
18668037 |
MIRT053098 |
hsa-miR-9-5p |
Luciferase reporter assay |
23525285 |
MIRT054795 |
hsa-miR-548d-5p |
Luciferase reporter assay, QRTPCR, Western blotting |
24929254 |
MIRT158798 |
hsa-miR-19a-3p |
HITS-CLIP |
22473208 |
MIRT158799 |
hsa-miR-19b-3p |
HITS-CLIP |
22473208 |
MIRT206051 |
hsa-miR-519c-3p |
HITS-CLIP |
23824327 |
MIRT437434 |
hsa-miR-33a-5p |
qRT-PCR, Western blot |
24100264 |
MIRT438762 |
hsa-miR-130a-3p |
Luciferase reporter assay |
24960162 |
MIRT445022 |
hsa-miR-27a-5p |
PAR-CLIP |
22100165 |
MIRT445022 |
hsa-miR-27a-5p |
Luciferase reporter assay, Western blot |
27910957 |
MIRT445023 |
hsa-miR-4699-5p |
PAR-CLIP |
22100165 |
MIRT445024 |
hsa-miR-4662b |
PAR-CLIP |
22100165 |
MIRT445025 |
hsa-miR-4647 |
PAR-CLIP |
22100165 |
MIRT445026 |
hsa-miR-4426 |
PAR-CLIP |
22100165 |
MIRT454319 |
hsa-miR-6788-5p |
PAR-CLIP |
23592263 |
MIRT454321 |
hsa-miR-30c-2-3p |
PAR-CLIP |
23592263 |
MIRT454322 |
hsa-miR-5006-5p |
PAR-CLIP |
23592263 |
MIRT454323 |
hsa-miR-30c-1-3p |
PAR-CLIP |
23592263 |
MIRT454324 |
hsa-miR-6778-5p |
PAR-CLIP |
23592263 |
MIRT454325 |
hsa-miR-1233-5p |
PAR-CLIP |
23592263 |
MIRT454326 |
hsa-miR-8085 |
PAR-CLIP |
23592263 |
MIRT454327 |
hsa-miR-6731-5p |
PAR-CLIP |
23592263 |
MIRT454328 |
hsa-miR-6878-5p |
PAR-CLIP |
23592263 |
MIRT454329 |
hsa-miR-6851-5p |
PAR-CLIP |
23592263 |
MIRT454330 |
hsa-miR-3689d |
PAR-CLIP |
23592263 |
MIRT454331 |
hsa-miR-6797-5p |
PAR-CLIP |
23592263 |
MIRT454332 |
hsa-miR-4755-3p |
PAR-CLIP |
23592263 |
MIRT454333 |
hsa-miR-1249-5p |
PAR-CLIP |
23592263 |
MIRT454334 |
hsa-miR-4459 |
PAR-CLIP |
23592263 |
MIRT454335 |
hsa-miR-6757-5p |
PAR-CLIP |
23592263 |
MIRT454336 |
hsa-miR-4779 |
PAR-CLIP |
23592263 |
MIRT609980 |
hsa-miR-6089 |
HITS-CLIP |
23824327 |
MIRT609981 |
hsa-miR-129-5p |
HITS-CLIP |
23824327 |
MIRT609982 |
hsa-miR-608 |
HITS-CLIP |
23824327 |
MIRT609983 |
hsa-miR-4651 |
HITS-CLIP |
23824327 |
MIRT615378 |
hsa-miR-6766-5p |
HITS-CLIP |
23824327 |
MIRT615379 |
hsa-miR-6756-5p |
HITS-CLIP |
23824327 |
MIRT640600 |
hsa-miR-335-3p |
HITS-CLIP |
23824327 |
MIRT640600 |
hsa-miR-335-3p |
HITS-CLIP |
27418678 |
MIRT640601 |
hsa-miR-1305 |
HITS-CLIP |
23824327 |
MIRT640601 |
hsa-miR-1305 |
HITS-CLIP |
27418678 |
MIRT640602 |
hsa-miR-607 |
HITS-CLIP |
23824327 |
MIRT640603 |
hsa-miR-4753-3p |
HITS-CLIP |
23824327 |
MIRT640603 |
hsa-miR-4753-3p |
HITS-CLIP |
27418678 |
MIRT640604 |
hsa-miR-3671 |
HITS-CLIP |
23824327 |
MIRT640604 |
hsa-miR-3671 |
HITS-CLIP |
27418678 |
MIRT640605 |
hsa-miR-130b-5p |
HITS-CLIP |
23824327 |
MIRT640605 |
hsa-miR-130b-5p |
HITS-CLIP |
27418678 |
MIRT640606 |
hsa-miR-5692a |
HITS-CLIP |
23824327 |
MIRT640606 |
hsa-miR-5692a |
HITS-CLIP |
27418678 |
MIRT732545 |
hsa-miR-34a-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
26330104 |
MIRT733074 |
hsa-miR-9-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
25592151 |
MIRT733266 |
hsa-miR-130b-3p |
qRT-PCR, Western blot |
26475357 |
MIRT733266 |
hsa-miR-130b-3p |
Luciferase reporter assay |
27364335 |
MIRT733437 |
hsa-miR-196b-5p |
Next Generation Sequencing (NGS), qRT-PCR |
28272430 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IDA |
9748239, 12700342 |
GO:0000785 |
Component |
Chromatin |
ISA |
|
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IDA |
9748239 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISA |
|
GO:0001103 |
Function |
RNA polymerase II repressing transcription factor binding |
IBA |
21873635 |
GO:0001103 |
Function |
RNA polymerase II repressing transcription factor binding |
IPI |
19955185 |
GO:0001223 |
Function |
Transcription coactivator binding |
IEA |
|
GO:0001227 |
Function |
DNA-binding transcription repressor activity, RNA polymerase II-specific |
IBA |
21873635 |
GO:0001227 |
Function |
DNA-binding transcription repressor activity, RNA polymerase II-specific |
IDA |
9748239 |
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IDA |
9748239 |
GO:0001666 |
Process |
Response to hypoxia |
IEA |
|
GO:0003677 |
Function |
DNA binding |
TAS |
10860941 |
GO:0003700 |
Function |
DNA-binding transcription factor activity |
IDA |
19955185 |
GO:0003700 |
Function |
DNA-binding transcription factor activity |
ISS |
|
GO:0003707 |
Function |
Steroid hormone receptor activity |
IDA |
19955185 |
GO:0004879 |
Function |
Nuclear receptor activity |
IBA |
21873635 |
GO:0004879 |
Function |
Nuclear receptor activity |
IDA |
12955147, 19955185 |
GO:0005515 |
Function |
Protein binding |
IPI |
9653119, 11915042, 16554032, 19955185, 21775429, 24043310, 24713062, 25814554, 32814053 |
GO:0005634 |
Component |
Nucleus |
IDA |
24639097 |
GO:0005634 |
Component |
Nucleus |
TAS |
16271724 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0006367 |
Process |
Transcription initiation from RNA polymerase II promoter |
TAS |
|
GO:0006631 |
Process |
Fatty acid metabolic process |
IBA |
21873635 |
GO:0007507 |
Process |
Heart development |
IEA |
|
GO:0008134 |
Function |
Transcription factor binding |
IPI |
26504087 |
GO:0008144 |
Function |
Drug binding |
IDA |
12955147 |
GO:0008270 |
Function |
Zinc ion binding |
IEA |
|
GO:0008289 |
Function |
Lipid binding |
IDA |
12955147 |
GO:0008544 |
Process |
Epidermis development |
IEA |
|
GO:0009267 |
Process |
Cellular response to starvation |
ISS |
|
GO:0009755 |
Process |
Hormone-mediated signaling pathway |
IBA |
21873635 |
GO:0010565 |
Process |
Regulation of cellular ketone metabolic process |
IDA |
19955185 |
GO:0010745 |
Process |
Negative regulation of macrophage derived foam cell differentiation |
IC |
12700342 |
GO:0010745 |
Process |
Negative regulation of macrophage derived foam cell differentiation |
IDA |
19114110 |
GO:0010876 |
Process |
Lipid localization |
IEA |
|
GO:0010887 |
Process |
Negative regulation of cholesterol storage |
IBA |
21873635 |
GO:0010887 |
Process |
Negative regulation of cholesterol storage |
IDA |
19114110 |
GO:0010891 |
Process |
Negative regulation of sequestering of triglyceride |
IDA |
12700342 |
GO:0019216 |
Process |
Regulation of lipid metabolic process |
IBA |
21873635 |
GO:0019216 |
Process |
Regulation of lipid metabolic process |
TAS |
|
GO:0019217 |
Process |
Regulation of fatty acid metabolic process |
IDA |
19955185 |
GO:0019902 |
Function |
Phosphatase binding |
IEA |
|
GO:0019904 |
Function |
Protein domain specific binding |
IEA |
|
GO:0030154 |
Process |
Cell differentiation |
IBA |
21873635 |
GO:0030512 |
Process |
Negative regulation of transforming growth factor beta receptor signaling pathway |
IDA |
31611175 |
GO:0030522 |
Process |
Intracellular receptor signaling pathway |
IEA |
|
GO:0031624 |
Function |
Ubiquitin conjugating enzyme binding |
IPI |
19955185 |
GO:0032000 |
Process |
Positive regulation of fatty acid beta-oxidation |
TAS |
16271724 |
GO:0032091 |
Process |
Negative regulation of protein binding |
IEA |
|
GO:0032099 |
Process |
Negative regulation of appetite |
ISS |
|
GO:0032868 |
Process |
Response to insulin |
IEA |
|
GO:0032922 |
Process |
Circadian regulation of gene expression |
ISS |
|
GO:0033993 |
Process |
Response to lipid |
IBA |
21873635 |
GO:0035095 |
Process |
Behavioral response to nicotine |
IEA |
|
GO:0042060 |
Process |
Wound healing |
IEA |
|
GO:0042157 |
Process |
Lipoprotein metabolic process |
IEA |
|
GO:0042752 |
Process |
Regulation of circadian rhythm |
ISS |
|
GO:0043401 |
Process |
Steroid hormone mediated signaling pathway |
IEA |
|
GO:0043565 |
Function |
Sequence-specific DNA binding |
ISS |
|
GO:0044877 |
Function |
Protein-containing complex binding |
IEA |
|
GO:0045070 |
Process |
Positive regulation of viral genome replication |
IMP |
22479552 |
GO:0045471 |
Process |
Response to ethanol |
IEA |
|
GO:0045722 |
Process |
Positive regulation of gluconeogenesis |
IEA |
|
GO:0045776 |
Process |
Negative regulation of blood pressure |
IEA |
|
GO:0045820 |
Process |
Negative regulation of glycolytic process |
IDA |
19955185 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IDA |
12955147 |
GO:0045923 |
Process |
Positive regulation of fatty acid metabolic process |
IBA |
21873635 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IDA |
9748239, 19955185, 20837115 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
ISS |
|
GO:0046321 |
Process |
Positive regulation of fatty acid oxidation |
ISS |
|
GO:0046889 |
Process |
Positive regulation of lipid biosynthetic process |
IMP |
25592151 |
GO:0050728 |
Process |
Negative regulation of inflammatory response |
IBA |
21873635 |
GO:0050728 |
Process |
Negative regulation of inflammatory response |
IDA |
21636785 |
GO:0051525 |
Function |
NFAT protein binding |
IEA |
|
GO:0051898 |
Process |
Negative regulation of protein kinase B signaling |
IMP |
31574452 |
GO:0061052 |
Process |
Negative regulation of cell growth involved in cardiac muscle cell development |
IEA |
|
GO:0070166 |
Process |
Enamel mineralization |
IEA |
|
GO:0097371 |
Function |
MDM2/MDM4 family protein binding |
IEA |
|
GO:1900016 |
Process |
Negative regulation of cytokine production involved in inflammatory response |
IMP |
31574452 |
GO:1901215 |
Process |
Negative regulation of neuron death |
IEA |
|
GO:1902894 |
Process |
Negative regulation of pri-miRNA transcription by RNA polymerase II |
IDA |
21636785 |
GO:1903038 |
Process |
Negative regulation of leukocyte cell-cell adhesion |
IDA |
21636785 |
GO:1903427 |
Process |
Negative regulation of reactive oxygen species biosynthetic process |
IMP |
31574452 |
GO:1903944 |
Process |
Negative regulation of hepatocyte apoptotic process |
IMP |
31574452 |
GO:2000191 |
Process |
Regulation of fatty acid transport |
TAS |
16271724 |
GO:2000272 |
Process |
Negative regulation of signaling receptor activity |
IDA |
12700342 |
GO:2001171 |
Process |
Positive regulation of ATP biosynthetic process |
IMP |
31574452 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q07869 |
Protein name |
Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1) |
Protein function |
Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2. |
PDB |
1I7G
,
1K7L
,
1KKQ
,
2NPA
,
2P54
,
2REW
,
2ZNN
,
3ET1
,
3FEI
,
3G8I
,
3KDT
,
3KDU
,
3SP6
,
3VI8
,
4BCR
,
4CI4
,
5AZT
,
5HYK
,
6KAX
,
6KAY
,
6KAZ
,
6KB0
,
6KB1
,
6KB2
,
6KB3
,
6KB4
,
6KB5
,
6KB6
,
6KB7
,
6KB8
,
6KB9
,
6KBA
,
6KXX
,
6KXY
,
6KYP
,
6L36
,
6L37
,
6L38
,
6L96
,
6LX4
,
6LX5
,
6LX6
,
6LX7
,
6LX8
,
6LX9
,
6LXA
,
6LXB
,
6LXC
,
7BPY
,
7BPZ
,
7BQ0
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00105 |
zf-C4 |
100 → 168 |
Zinc finger, C4 type (two domains) |
Domain |
PF00104 |
Hormone_recep |
264 → 449 |
Ligand-binding domain of nuclear hormone receptor |
Domain |
|
Sequence |
|
Sequence length |
468 |
Interactions |
View interactions |
|
|